Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Amir I Tukhvatullin"'
Publikováno v:
The Lancet
Lancet (London, England)
Lancet (London, England)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad251331fe14a3d992ff632a12357eef
Autor:
Tatiana A Ozharovskaya, Nadezhda L. Lubenets, Sergei V. Borisevich, Alexander S. Semikhin, Daria M. Grousova, Andrei G. Botikov, Yana V. Simakova, Fatima M. Izhaeva, Alina S. Erokhova, Denis I. Zrelkin, Olga V. Zubkova, Irina A Favorskaya, Elena A Smolyarchuk, Boris S. Naroditsky, M M Shmarov, Natalia A. Nikitenko, Alina S. Dzharullaeva, Alexander L. Gintsburg, Morozova Lf, Daria A. Egorova, Evgeny V Kryukov, Dmitry V. Shcheblyakov, Olga Popova, Denis Y. Logunov, Dmitry N. Shcherbinin, Inna V. Dolzhikova, Amir I Tukhvatullin, Elizaveta A. Tokarskaya, Ilias B Esmagambetov, Vladimir F Babira, Anna V. Kovyrshina, Daria V Voronina
Publikováno v:
Yana Simakova
Lancet (London, England)
The Lancet
Lancet (London, England)
The Lancet
Summary Background We developed a heterologous COVID-19 vaccine consisting of two components, a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (rAd5) vector, both carrying the gene for severe acute respiratory syndr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b04ada67ad427528778d88936c6006e
